Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunocontraception with zona pellucida proteins.

M Paterson1, Z A Jennings, M van Duin

  • 1MRC Reproductive Biology Unit, Edinburgh, UK. m.paterson@ed-rbu.mrc.ac.uk

Cells, Tissues, Organs
|March 24, 2000
PubMed
Summary

Developing an immunological contraception targeting the zona pellucida (ZP) shows promise but requires further research. Current studies aim to identify safe and effective ZP3 epitopes for reversible infertility without adverse ovarian effects.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The impact of junk food on male fertility in mice: therapeutic interventions targeting advanced glycation end-products and oxidative stress.

Scientific reports·2026
Same author

Epidemiological insights into the burden of feline upper respiratory tract infections in Queensland RSPCA shelters.

Australian veterinary journal·2023
Same author

Diagnosis of Human Sperm Function.

Development, growth & differentiation·2023
Same author

The longitudinal loss of islet autoantibody responses from diagnosis of type 1 diabetes occurs progressively over follow-up and is determined by low autoantibody titres, early-onset, and genetic variants.

Clinical and experimental immunology·2022
Same author

Mechanical biofilm disruption causes microbial and immunological shifts in periodontitis patients.

Scientific reports·2021
Same author

Kisspeptin treatment induces gonadotropic responses and rescues ovulation in a subset of preclinical models and women with polycystic ovary syndrome.

Human reproduction (Oxford, England)·2019

Area of Science:

  • Immunology
  • Reproductive Biology
  • Contraception Development

Background:

  • Immunocontraception targeting the zona pellucida (ZP) offers a potential method to disrupt fertilization.
  • Previous attempts using ZP antigens led to ovarian pathology and infertility in animal models.
  • Careful selection of B-cell epitopes is crucial to avoid adverse autoimmune reactions.

Purpose of the Study:

  • To identify primate ZP3 epitopes for developing safe and effective immunocontraceptives.
  • To evaluate the efficacy and safety of chimeric vaccines containing ZP3 epitopes.
  • To assess the potential for reversible infertility without detrimental ovarian effects.

Main Methods:

  • Epitope-mapping studies were conducted on primate ZP3.
  • Chimeric vaccines incorporating T-helper cell epitopes were designed and tested in vivo.

Related Experiment Videos

  • Antibody binding to ZP and in vitro sperm-egg binding assays were performed.
  • Pregnancy rates in immunized animals were monitored.

    • Main Results:

    • Vaccines containing single and triple peptide epitopes showed no detrimental effects on ovarian function.
    • High-titer antibodies specifically bound to marmoset and human ZP.
    • In vitro human sperm-egg binding was reduced by approximately 60%.
    • No pregnancy prevention was observed in actively immunized female marmosets.

    Conclusions:

    • While primate ZP3 epitopes can elicit antibodies that inhibit sperm-egg binding, they did not induce infertility in marmosets.
    • Further research is necessary to identify optimal ZP3 epitope combinations for safe and effective immunocontraception.
    • Developing a reversible contraceptive vaccine free of side effects remains a significant challenge.